Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.23 trillion, total revenue of $4.56 trillion and a weighted average PE ratio of 42.41.
Market Cap
8.23T
Revenue
4.56T
Profits
194.02B
PE Ratio
42.41
Profit Margin
4.25%
Dividend Yield
0.43%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 881.47B | 2.12% | 1,674,225 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 543.65B | 0.73% | 2,244,640 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 364.58B | -0.98% | 1,942,988 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 329.42B | -2.17% | 3,712,580 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 285.54B | -1.08% | 1,816,582 | 60.44B |
| 6 | MRK | Merck & Co., Inc. | 280.79B | 0.51% | 3,725,492 | 65.77B |
| 7 | NVS | Novartis AG | 277.41B | 0.66% | 868,937 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 196.49B | 1.60% | 13,421,554 | 48.59B |
| 9 | AMGN | Amgen Inc. | 176.09B | 0.74% | 1,490,214 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 173.30B | 0.81% | 1,169,621 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 164.66B | -0.02% | 2,391,985 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 159.47B | -0.46% | 1,671,792 | 10.58B |
| 13 | ABT | Abbott Laboratories | 152.55B | 0.05% | 10,383,049 | 45.13B |
| 14 | PFE | Pfizer Inc. | 150.40B | 0.53% | 35,474,277 | 63.32B |
| 15 | DHR | Danaher Corporation | 124.23B | 0.85% | 1,935,742 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 115.97B | -1.03% | 6,051,561 | 48.48B |
| 17 | SYK | Stryker Corporation | 113.17B | 1.59% | 1,862,419 | 25.27B |
| 18 | SNY | Sanofi | 109.25B | - | 1,482,907 | 54.60B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 107.38B | -1.72% | 1,209,041 | 12.22B |
| 20 | CVS | CVS Health Corporation | 103.78B | -1.26% | 3,305,669 | 399.83B |
| 21 | GSK | GSK plc | 103.40B | -0.92% | 2,384,890 | 43.29B |
| 22 | MDT | Medtronic plc | 100.13B | -0.40% | 5,013,284 | 35.48B |
| 23 | MCK | McKesson Corporation | 98.78B | -0.17% | 483,195 | 397.96B |
| 24 | HCA | HCA Healthcare, Inc. | 95.61B | 0.89% | 334,749 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 83.38B | -1.32% | 7,050,627 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 80.33B | -0.54% | 708,295 | 200.42B |
| 27 | CI | The Cigna Group | 72.83B | -1.45% | 863,941 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 71.44B | -0.99% | 283,631 | 14.92B |
| 29 | COR | Cencora, Inc. | 59.31B | 0.41% | 675,157 | 325.78B |
| 30 | MDLN | Medline Inc. | 59.09B | 1.79% | 1,886,278 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 52.81B | -0.06% | 1,300,630 | 28.48B |
| 32 | ARGX | argenx SE | 49.39B | -1.93% | 158,256 | 4.24B |
| 33 | EW | Edwards Lifesciences Corporation | 47.74B | -0.64% | 1,378,388 | 6.30B |
| 34 | ZTS | Zoetis Inc. | 47.46B | 0.15% | 1,603,075 | 9.47B |
| 35 | CAH | Cardinal Health, Inc. | 45.87B | -0.61% | 524,037 | 250.74B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.53B | 1.80% | 391,473 | 4.45B |
| 37 | HLN | Haleon plc | 41.63B | -0.49% | 4,753,739 | 14.85B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 41.50B | 0.82% | 3,439,496 | 17.35B |
| 39 | BDX | Becton, Dickinson and Company | 41.27B | -0.93% | 1,638,899 | 21.92B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.04B | 0.67% | 345,099 | 4.29B |
| 41 | ALC | Alcon Inc. | 36.06B | 1.48% | 1,191,594 | 10.40B |
| 42 | WAT | Waters Corporation | 33.29B | 12.35% | 1,403,641 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 33.15B | 4.57% | 1,500,200 | 7.07B |
| 44 | ONC | BeOne Medicines AG | 32.78B | -0.74% | 72,660 | 5.34B |
| 45 | RVMD | Revolution Medicines, Inc. | 30.84B | -0.87% | 873,695 | - |
| 46 | INSM | Insmed Incorporated | 30.12B | -0.33% | 597,555 | 606.42M |
| 47 | RMD | ResMed Inc. | 30.09B | -0.95% | 1,037,593 | 5.54B |
| 48 | RPRX | Royalty Pharma plc | 30.04B | 0.96% | 1,533,094 | 2.38B |
| 49 | NTRA | Natera, Inc. | 29.68B | -1.73% | 765,105 | 2.31B |
| 50 | IQV | IQVIA Holdings Inc. | 29.34B | 8.62% | 2,255,631 | 16.31B |
| 51 | HUM | Humana Inc. | 28.87B | 1.04% | 575,468 | 137.20B |
| 52 | VEEV | Veeva Systems Inc. | 28.14B | 1.22% | 2,394,079 | 3.20B |
| 53 | BIIB | Biogen Inc. | 27.84B | 0.74% | 204,033 | 9.94B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 27.61B | -0.51% | 4,688,720 | 20.98B |
| 55 | MTD | Mettler-Toledo International Inc. | 26.45B | 3.62% | 63,450 | 4.03B |
| 56 | CNC | Centene Corporation | 26.45B | - | 2,480,434 | 178.33B |
| 57 | UTHR | United Therapeutics Corporation | 25.15B | -1.26% | 199,412 | 3.18B |
| 58 | PHG | Koninklijke Philips N.V. | 25.06B | 0.76% | 891,199 | 20.94B |
| 59 | BNTX | BioNTech SE | 24.12B | -4.01% | 958,119 | 3.23B |
| 60 | DXCM | DexCom, Inc. | 22.94B | -0.97% | 1,847,701 | 4.82B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.79B | 2.77% | 321,598 | 3.22B |
| 62 | DGX | Quest Diagnostics Incorporated | 21.17B | -0.13% | 213,264 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.03B | 1.37% | 290,379 | 14.14B |
| 64 | STE | STERIS plc | 20.97B | 0.73% | 236,753 | 5.83B |
| 65 | ILMN | Illumina, Inc. | 20.77B | -1.49% | 573,326 | 4.39B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.16B | -0.65% | 1,024,429 | 13.31M |
| 67 | INCY | Incyte Corporation | 19.37B | -0.19% | 366,473 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 18.33B | -2.33% | 2,880,186 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.07B | 2.11% | 9,915,587 | 14.30B |
| 70 | GMAB | Genmab A/S | 16.69B | 0.83% | 468,397 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.17B | 1.27% | 875,394 | 21.46B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.11B | 0.70% | 746,514 | 8.41B |
| 73 | ASND | Ascendis Pharma A/S | 14.03B | -0.73% | 158,926 | 845.52M |
| 74 | SMMT | Summit Therapeutics Inc. | 13.55B | 2.83% | 3,049,454 | - |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 13.38B | -0.81% | 695,530 | 2.86B |
| 76 | SNN | Smith & Nephew plc | 13.35B | 1.49% | 1,581,031 | 6.16B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.34B | -1.40% | 54,624 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.28B | -1.67% | 1,378,206 | 502.08M |
| 79 | JAZZ | Jazz Pharmaceuticals plc | 13.01B | 1.58% | 587,060 | 4.27B |
| 80 | PEN | Penumbra, Inc. | 12.76B | -0.09% | 204,379 | 1.40B |
| 81 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | -0.56% | 353,222 | 1.06B |
| 82 | MEDP | Medpace Holdings, Inc. | 12.39B | 4.06% | 224,971 | 2.68B |
| 83 | GMED | Globus Medical, Inc. | 12.24B | -0.41% | 473,364 | 2.94B |
| 84 | ALGN | Align Technology, Inc. | 12.13B | -1.49% | 328,125 | 4.10B |
| 85 | COO | The Cooper Companies, Inc. | 11.99B | -0.10% | 1,036,888 | 4.15B |
| 86 | SOLV | Solventum Corporation | 11.87B | 1.53% | 919,793 | 8.33B |
| 87 | GH | Guardant Health, Inc. | 11.69B | -2.25% | 516,185 | 982.02M |
| 88 | PODD | Insulet Corporation | 11.64B | -1.98% | 618,525 | 2.71B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.58B | -2.69% | 208,501 | 958.40M |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.57B | 2.93% | 2,363,927 | 4.72B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 11.48B | -0.28% | 553,552 | 708.24M |
| 92 | EXEL | Exelixis, Inc. | 11.24B | 0.23% | 1,949,505 | 2.32B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.13B | -0.26% | 1,155,821 | 3.85B |
| 94 | FMS | Fresenius Medical Care AG | 10.95B | -11.35% | 1,944,513 | 22.32B |
| 95 | BTSG | BrightSpring Health Services, Inc. | 10.65B | -3.23% | 1,854,059 | 13.65B |
| 96 | RVTY | Revvity, Inc. | 10.43B | 7.83% | 1,201,209 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 10.35B | -2.19% | 372,671 | 6.07B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.33B | -3.46% | 758,303 | 1.09B |
| 99 | ENSG | The Ensign Group, Inc. | 10.32B | -2.15% | 260,148 | 5.27B |
| 100 | DVA | DaVita Inc. | 10.29B | 1.25% | 772,316 | 13.64B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.28B | -4.08% | 1,897,323 | 3.24B |
| 102 | UHS | Universal Health Services, Inc. | 10.17B | 0.33% | 444,679 | 17.76B |
| 103 | MOH | Molina Healthcare, Inc. | 10.07B | -1.12% | 371,014 | 43.10B |
| 104 | TEM | Tempus AI, Inc. | 9.70B | -3.03% | 3,367,886 | 1.27B |
| 105 | CYTK | Cytokinetics, Incorporated | 9.63B | 17.34% | 14,024,918 | 88.04M |
| 106 | MASI | Masimo Corporation | 9.32B | 0.16% | 621,173 | 1.53B |
| 107 | ABVX | ABIVAX Société Anonyme | 9.27B | 4.54% | 1,005,151 | 5.37M |
| 108 | ICLR | ICON Public Limited Company | 9.19B | 7.46% | 760,615 | 8.10B |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 9.13B | -2.86% | 233,843 | 7.46M |
| 110 | CRL | Charles River Laboratories International, Inc. | 9.06B | 6.55% | 484,932 | 4.02B |
| 111 | TECH | Bio-Techne Corporation | 8.84B | 3.23% | 1,406,960 | 1.22B |
| 112 | BAX | Baxter International Inc. | 8.70B | 1.38% | 3,373,418 | 11.32B |
| 113 | HSIC | Henry Schein, Inc. | 8.44B | 2.18% | 1,335,154 | 13.38B |
| 114 | KRYS | Krystal Biotech, Inc. | 8.40B | -0.69% | 260,804 | 417.30M |
| 115 | PCVX | Vaxcyte, Inc. | 7.95B | -5.85% | 1,112,066 | - |
| 116 | NUVL | Nuvalent, Inc. | 7.93B | -1.76% | 284,616 | - |
| 117 | IBRX | ImmunityBio, Inc. | 7.90B | 2.96% | 6,470,533 | 113.29M |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.87B | 2.82% | 840,219 | 1.40B |
| 119 | ATR | AptarGroup, Inc. | 7.84B | 1.83% | 301,197 | 3.87B |
| 120 | GKOS | Glaukos Corporation | 7.83B | -1.78% | 377,975 | 551.35M |
| 121 | RGEN | Repligen Corporation | 7.12B | 6.79% | 1,317,209 | 763.34M |
| 122 | QGEN | Qiagen N.V. | 7.02B | -0.09% | 712,858 | 2.09B |
| 123 | HQY | HealthEquity, Inc. | 6.97B | 0.35% | 248,819 | 1.31B |
| 124 | BIO | Bio-Rad Laboratories, Inc. | 6.91B | 0.14% | 200,923 | 2.59B |
| 125 | CELC | Celcuity Inc. | 6.79B | -3.16% | 1,063,692 | - |
| 126 | KYMR | Kymera Therapeutics, Inc. | 6.77B | -1.50% | 213,645 | 51.48M |
| 127 | GRFS | Grifols, S.A. | 6.60B | 0.24% | 146,480 | 8.83B |
| 128 | MIRM | Mirum Pharmaceuticals, Inc. | 6.52B | 1.03% | 733,040 | 521.31M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.34B | -0.15% | 216,666 | 46.02M |
| 130 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.27B | 7.26% | 1,417,907 | 217.17M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 6.24B | 4.59% | 871,418 | - |
| 132 | APGE | Apogee Therapeutics, Inc. | 6.20B | -0.60% | 172,005 | - |
| 133 | COGT | Cogent Biosciences, Inc. | 6.20B | -1.28% | 902,593 | - |
| 134 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.10% | 478,129 | 15.00M |
| 135 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | - | - | - |
| 136 | BLTE | Belite Bio, Inc | 6.11B | 0.58% | 37,281 | - |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.07B | -2.27% | 9,709,053 | 2.35B |
| 138 | ALKS | Alkermes plc | 5.92B | 4.27% | 1,687,913 | 1.56B |
| 139 | CGON | CG Oncology, Inc. | 5.88B | -1.30% | 450,058 | 4.04M |
| 140 | BRKR | Bruker Corporation | 5.79B | 4.53% | 1,224,564 | 3.44B |
| 141 | BLCO | Bausch + Lomb Corporation | 5.74B | -1.17% | 186,079 | 5.10B |
| 142 | CHE | Chemed Corporation | 5.66B | 0.57% | 128,101 | 2.54B |
| 143 | LNTH | Lantheus Holdings, Inc. | 5.62B | -1.46% | 288,330 | 1.54B |
| 144 | IMVT | Immunovant, Inc. | 5.59B | -1.40% | 501,448 | - |
| 145 | CORT | Corcept Therapeutics Incorporated | 5.54B | 0.03% | 442,639 | 769.10M |
| 146 | AVTR | Avantor, Inc. | 5.53B | 1.44% | 2,737,030 | 6.55B |
| 147 | XENE | Xenon Pharmaceuticals Inc. | 5.53B | -0.40% | 855,000 | 7.50M |
| 148 | SRRK | Scholar Rock Holding Corporation | 5.46B | -1.53% | 186,569 | - |
| 149 | OSCR | Oscar Health, Inc. | 5.44B | -2.64% | 4,984,688 | 11.70B |
| 150 | PTCT | PTC Therapeutics, Inc. | 5.38B | -1.01% | 349,142 | 1.73B |
| 151 | TFX | Teleflex Incorporated | 5.32B | 0.23% | 332,503 | 1.99B |
| 152 | TGTX | TG Therapeutics, Inc. | 5.30B | 0.49% | 857,915 | 616.29M |
| 153 | LEGN | Legend Biotech Corporation | 5.25B | 7.21% | 5,265,479 | 1.03B |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 2,227,687 | 1.00B |
| 155 | CAI | Caris Life Sciences, Inc. | 5.21B | -1.34% | 740,646 | 812.03M |
| 156 | PACS | PACS Group, Inc. | 5.14B | 0.65% | 112,064 | 5.29B |
| 157 | STVN | Stevanato Group S.p.A. | 5.01B | 3.09% | 155,849 | 1.39B |
| 158 | CRSP | CRISPR Therapeutics AG | 4.96B | -3.80% | 2,226,094 | 4.10M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.84B | -0.45% | 184,794 | 2.04M |
| 160 | RDNT | RadNet, Inc. | 4.77B | 4.69% | 384,062 | 2.04B |
| 161 | DOCS | Doximity, Inc. | 4.70B | 2.25% | 1,299,168 | 637.78M |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.63B | 1.10% | 52,086 | 268.09M |
| 163 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.32B | -2.50% | 336,700 | 754.05M |
| 164 | SHC | Sotera Health Company | 4.29B | -2.21% | 5,377,384 | 1.19B |
| 165 | NVST | Envista Holdings Corporation | 4.28B | 1.78% | 903,355 | 2.72B |
| 166 | AMRX | Amneal Pharmaceuticals, Inc. | 4.27B | 2.06% | 645,489 | 3.02B |
| 167 | MANE | Veradermics, Incorporated | 4.26B | 8.29% | 621,205 | - |
| 168 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.26B | -1.48% | 408,148 | 7.70M |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.07B | -2.03% | 2,240,371 | 536.20M |
| 170 | HNGE | Hinge Health, Inc. | 4.05B | 7.08% | 3,490,536 | 587.86M |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.04B | 19.55% | 3,287,410 | - |
| 172 | ORKA | Oruka Therapeutics, Inc. | 3.99B | 0.42% | 823,285 | - |
| 173 | WAY | Waystar Holding Corp. | 3.94B | -1.53% | 1,404,606 | 1.16B |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.87B | -1.11% | 297,289 | 787.85M |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.82B | 0.45% | 471,178 | 1.07B |
| 176 | ALHC | Alignment Healthcare, Inc. | 3.77B | -5.35% | 3,526,838 | 4.26B |
| 177 | TLX | Telix Pharmaceuticals Limited | 3.75B | -0.54% | 60,302 | 803.79M |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.69B | 4.35% | 1,684,307 | 588.99M |
| 179 | MMSI | Merit Medical Systems, Inc. | 3.63B | -2.00% | 301,769 | 1.54B |
| 180 | BLLN | BillionToOne, Inc. | 3.61B | 8.75% | 1,300,692 | 305.11M |
| 181 | VKTX | Viking Therapeutics, Inc. | 3.60B | -2.42% | 1,381,811 | - |
| 182 | LQDA | Liquidia Corporation | 3.55B | 3.74% | 599,000 | 158.32M |
| 183 | TWST | Twist Bioscience Corporation | 3.52B | 0.68% | 914,806 | 409.48M |
| 184 | OGN | Organon & Co. | 3.50B | 0.49% | 4,193,080 | 6.16B |
| 185 | OPCH | Option Care Health, Inc. | 3.38B | 1.84% | 3,391,457 | 5.67B |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.37B | -1.72% | 460,102 | 22.50M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.34B | 0.29% | 888,094 | 3.05B |
| 188 | TMDX | TransMedics Group, Inc. | 3.31B | -1.41% | 855,698 | 605.49M |
| 189 | ALMS | Alumis Inc. | 3.28B | 2.18% | 582,278 | 24.05M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.26B | -0.35% | 991,556 | 62.38M |
| 191 | MMED | MiniMed Group, Inc. | 3.26B | -2.15% | 271,912 | 2.99B |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.19B | -2.61% | 504,021 | 247.00M |
| 193 | LIVN | LivaNova PLC | 3.17B | -1.85% | 796,715 | 1.39B |
| 194 | KLRA | Kailera Therapeutics, Inc. | 3.11B | -4.42% | 217,549 | - |
| 195 | ERAS | Erasca, Inc. | 3.09B | -1.82% | 2,578,974 | - |
| 196 | PRVA | Privia Health Group, Inc. | 3.06B | 0.50% | 490,835 | 2.12B |
| 197 | DNLI | Denali Therapeutics Inc. | 2.95B | -0.54% | 1,455,633 | - |
| 198 | GPCR | Structure Therapeutics Inc. | 2.94B | -4.04% | 410,950 | - |
| 199 | ICUI | ICU Medical, Inc. | 2.93B | -1.13% | 76,126 | 2.23B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 2.91B | -0.81% | 442,991 | 376.07M |
| 201 | CON | Concentra Group Holdings Parent, Inc. | 2.91B | -0.18% | 295,435 | 2.16B |
| 202 | ITGR | Integer Holdings Corporation | 2.90B | 1.70% | 287,214 | 1.86B |
| 203 | BEAM | Beam Therapeutics Inc. | 2.89B | -4.02% | 1,294,787 | 139.74M |
| 204 | LFST | LifeStance Health Group, Inc. | 2.86B | 1.58% | 1,396,497 | 1.42B |
| 205 | NKTR | Nektar Therapeutics | 2.84B | -3.16% | 413,714 | 55.23M |
| 206 | TXG | 10x Genomics, Inc. | 2.84B | 1.52% | 976,278 | 642.82M |
| 207 | DYN | Dyne Therapeutics, Inc. | 2.84B | -3.11% | 544,947 | - |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.80B | - | 423,808 | 718.95M |
| 209 | TARS | Tarsus Pharmaceuticals, Inc. | 2.74B | -0.31% | 164,434 | 451.36M |
| 210 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.03% | 1,132,543 | 190.41M |
| 211 | VCYT | Veracyte, Inc. | 2.68B | 0.37% | 693,240 | 517.15M |
| 212 | WRBY | Warby Parker Inc. | 2.65B | -1.50% | 1,214,677 | 871.91M |
| 213 | KOD | Kodiak Sciences Inc. | 2.65B | 1.14% | 517,323 | - |
| 214 | PBH | Prestige Consumer Healthcare Inc. | 2.65B | 1.22% | 328,782 | 1.10B |
| 215 | NHC | National HealthCare Corporation | 2.60B | -2.32% | 34,361 | 1.52B |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.60B | 1.10% | 302,366 | 1.55M |
| 217 | IMNM | Immunome, Inc. | 2.60B | -1.67% | 392,241 | 6.94M |
| 218 | HAE | Haemonetics Corporation | 2.58B | 0.51% | 239,609 | 1.32B |
| 219 | IRON | Disc Medicine, Inc. | 2.58B | -0.04% | 115,991 | - |
| 220 | LMAT | LeMaitre Vascular, Inc. | 2.58B | 1.21% | 105,156 | 249.60M |
| 221 | HTFL | HeartFlow, Inc. | 2.52B | 1.02% | 383,147 | 176.03M |
| 222 | IDYA | IDEAYA Biosciences, Inc. | 2.51B | -1.28% | 308,056 | 225.27M |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.47B | -0.83% | 222,833 | - |
| 224 | VERA | Vera Therapeutics, Inc. | 2.46B | -3.55% | 507,483 | - |
| 225 | RLAY | Relay Therapeutics, Inc. | 2.43B | -2.06% | 1,027,833 | 15.36M |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.41B | -0.81% | 690,454 | 673.00M |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.41B | 1.52% | 583,010 | - |
| 228 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -2.23% | 337,211 | - |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.38B | -6.38% | 1,789,787 | 3.37B |
| 230 | ADMA | ADMA Biologics, Inc. | 2.36B | -1.50% | 3,257,733 | 510.17M |
| 231 | ZLAB | Zai Lab Limited | 2.36B | -1.13% | 105,456 | 460.16M |
| 232 | GRDN | Guardian Pharmacy Services, Inc. | 2.34B | 0.75% | 107,245 | 1.45B |
| 233 | PAHC | Phibro Animal Health Corporation | 2.31B | 4.19% | 76,651 | 1.46B |
| 234 | AXGN | Axogen, Inc. | 2.31B | 1.85% | 288,297 | 238.11M |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.31B | -1.30% | 1,434,073 | 874.84M |
| 236 | HCM | HUTCHMED (China) Limited | 2.29B | 0.34% | 7,381 | 548.51M |
| 237 | GRAL | GRAIL, Inc. | 2.25B | -1.31% | 307,986 | 147.17M |
| 238 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | -3.18% | 1,048,409 | 2.20B |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 2.25B | 0.18% | 6,826,967 | 3.68B |
| 240 | ADPT | Adaptive Biotechnologies Corporation | 2.21B | -4.48% | 1,340,558 | 276.98M |
| 241 | ESTA | Establishment Labs Holdings Inc. | 2.11B | 2.14% | 360,539 | 211.08M |
| 242 | BHC | Bausch Health Companies Inc. | 2.10B | 1.72% | 845,354 | 10.53B |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 0.92% | 596,277 | 283.06M |
| 244 | SEM | Select Medical Holdings Corporation | 2.04B | 0.03% | 365,564 | 5.52B |
| 245 | TRVI | Trevi Therapeutics, Inc. | 2.03B | 0.83% | 446,490 | - |
| 246 | MESO | Mesoblast Limited | 2.03B | -1.75% | 44,443 | 65.38M |
| 247 | STOK | Stoke Therapeutics, Inc. | 2.02B | -5.00% | 196,678 | 184.42M |
| 248 | AAPG | Ascentage Pharma Group International | 2.01B | 0.84% | 331 | 82.08M |
| 249 | NEOG | Neogen Corporation | 2.00B | 1.10% | 571,902 | 870.56M |
| 250 | ANAB | AnaptysBio, Inc. | 2.00B | -0.40% | 244,599 | 234.60M |
| 251 | TYRA | Tyra Biosciences, Inc. | 1.99B | -4.68% | 226,621 | - |
| 252 | OCUL | Ocular Therapeutix, Inc. | 1.98B | -6.76% | 2,330,578 | 52.04M |
| 253 | OMCL | Omnicell, Inc. | 1.98B | 0.02% | 260,353 | 1.23B |
| 254 | PHVS | Pharvaris N.V. | 1.97B | 0.32% | 406,214 | - |
| 255 | ZYME | Zymeworks Inc. | 1.97B | -0.41% | 212,799 | 105.97M |
| 256 | SGRY | Surgery Partners, Inc. | 1.95B | 5.92% | 1,495,746 | 3.34B |
| 257 | GENB | Generate Biomedicines, Inc. | 1.95B | 5.74% | 151,546 | 31.89M |
| 258 | TSHA | Taysha Gene Therapies, Inc. | 1.93B | 1.20% | 764,319 | 9.77M |
| 259 | VRDN | Viridian Therapeutics, Inc. | 1.92B | 32.65% | 12,077,430 | 70.92M |
| 260 | ANIP | ANI Pharmaceuticals, Inc. | 1.92B | 2.50% | 131,065 | 883.37M |
| 261 | HRMY | Harmony Biosciences Holdings, Inc. | 1.88B | -0.06% | 273,547 | 868.45M |
| 262 | CAPR | Capricor Therapeutics, Inc. | 1.87B | -3.37% | 429,182 | 11.13M |
| 263 | INBX | Inhibrx Biosciences, Inc. | 1.87B | 0.16% | 222,074 | 1.30M |
| 264 | VCEL | Vericel Corporation | 1.87B | 0.71% | 251,251 | 276.26M |
| 265 | NTLA | Intellia Therapeutics, Inc. | 1.87B | -3.68% | 3,209,458 | 67.67M |
| 266 | GLPG | Galapagos NV | 1.87B | -0.49% | 49,216 | 1.31B |
| 267 | NVCR | NovoCure Limited | 1.85B | -5.67% | 1,009,271 | 674.41M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.84B | 0.64% | 111,494 | - |
| 269 | SION | Sionna Therapeutics, Inc. | 1.84B | 0.52% | 221,512 | - |
| 270 | AHG | Akso Health Group | 1.81B | -1.40% | 172,184 | 14.84M |
| 271 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.78B | -2.55% | 585,922 | -665.00K |
| 272 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | -4.55% | 8,429,904 | 74.68M |
| 273 | SNDA | Sonida Senior Living, Inc. | 1.77B | 1.22% | 242,053 | 336.39M |
| 274 | ADUS | Addus HomeCare Corporation | 1.76B | -3.70% | 437,687 | 1.45B |
| 275 | ASTH | Astrana Health, Inc. | 1.75B | 1.29% | 181,883 | 3.18B |
| 276 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -1.43% | 737,737 | 217.17M |
| 277 | ARDX | Ardelyx, Inc. | 1.73B | -3.97% | 3,432,485 | 427.68M |
| 278 | AORT | Artivion, Inc. | 1.73B | 0.42% | 86,957 | 441.33M |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -2.78% | 883,804 | 71.78M |
| 280 | INVA | Innoviva, Inc. | 1.70B | -0.30% | 250,604 | 411.33M |
| 281 | RAPP | Rapport Therapeutics, Inc. | 1.68B | -1.15% | 60,296 | - |
| 282 | MD | Pediatrix Medical Group, Inc. | 1.66B | -8.46% | 894,852 | 1.93B |
| 283 | NUVB | Nuvation Bio Inc. | 1.66B | 7.94% | 7,949,889 | 143.05M |
| 284 | NBTX | Nanobiotix S.A. | 1.65B | 10.40% | 71,305 | 38.27M |
| 285 | OCS | Oculis Holding AG | 1.65B | -1.42% | 350,103 | 1.51M |
| 286 | UFPT | UFP Technologies, Inc. | 1.63B | 10.09% | 374,175 | 608.85M |
| 287 | IOVA | Iovance Biotherapeutics, Inc. | 1.63B | 2.60% | 13,468,057 | 263.50M |
| 288 | AHCO | AdaptHealth Corp. | 1.62B | -8.51% | 3,066,684 | 3.29B |
| 289 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -1.23% | 350,603 | 66.05M |
| 290 | VIR | Vir Biotechnology, Inc. | 1.61B | -1.87% | 436,988 | 68.56M |
| 291 | ALMR | Alamar Biosciences, Inc. | 1.60B | -1.16% | 76,224 | 74.21M |
| 292 | PRGO | Perrigo Company plc | 1.60B | 2.02% | 830,912 | 4.25B |
| 293 | DMRA | Damora Therapeutics, Inc. | 1.53B | -1.97% | 66,288 | - |
| 294 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -2.15% | 253,570 | 123.67M |
| 295 | ATEC | Alphatec Holdings, Inc. | 1.53B | -2.37% | 3,024,233 | 764.16M |
| 296 | PGEN | Precigen, Inc. | 1.51B | 3.38% | 2,848,314 | 9.68M |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.50B | 3.32% | 205,518 | 1.85B |
| 298 | HROW | Harrow, Inc. | 1.49B | -0.25% | 240,672 | 272.30M |
| 299 | BCAX | Bicara Therapeutics Inc. | 1.49B | 0.09% | 211,351 | - |
| 300 | PGNY | Progyny, Inc. | 1.48B | -0.21% | 518,775 | 1.29B |
| 301 | IMTX | Immatics N.V. | 1.48B | -1.17% | 278,459 | 56.67M |
| 302 | ATRC | AtriCure, Inc. | 1.47B | 1.04% | 399,894 | 534.53M |
| 303 | ATAI | AtaiBeckley Inc. | 1.46B | -5.48% | 2,589,896 | 4.09M |
| 304 | MAZE | Maze Therapeutics, Inc. | 1.45B | -2.34% | 341,882 | 2.50M |
| 305 | ARDT | Ardent Health, Inc. | 1.44B | 1.00% | 265,581 | 6.32B |
| 306 | FTRE | Fortrea Holdings Inc. | 1.44B | 23.92% | 2,628,621 | 2.71B |
| 307 | IMCR | Immunocore Holdings plc | 1.43B | -1.44% | 94,383 | 400.02M |
| 308 | BHVN | Biohaven Ltd. | 1.42B | -6.76% | 2,942,432 | - |
| 309 | PRCT | PROCEPT BioRobotics Corporation | 1.41B | - | 345,547 | 322.02M |
| 310 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | -2.11% | 303,995 | 2.43B |
| 311 | ABCL | AbCellera Biologics Inc. | 1.40B | 0.54% | 11,127,072 | 75.13M |
| 312 | MBX | MBX Biosciences, Inc. | 1.40B | -0.37% | 147,474 | - |
| 313 | ENOV | Enovis Corporation | 1.38B | 3.04% | 468,103 | 2.25B |
| 314 | STAA | STAAR Surgical Company | 1.38B | 1.94% | 435,000 | 239.44M |
| 315 | WVE | Wave Life Sciences Ltd. | 1.37B | -4.42% | 1,902,313 | 71.80M |
| 316 | INSP | Inspire Medical Systems, Inc. | 1.37B | -13.15% | 2,886,372 | 915.25M |
| 317 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.17% | 3,001,975 | 73.62M |
| 318 | CLOV | Clover Health Investments, Corp. | 1.37B | -1.70% | 2,324,269 | 1.92B |
| 319 | NNNN | Anbio Biotechnology | 1.33B | 0.90% | 26,335 | 8.65M |
| 320 | GHRS | GH Research PLC | 1.32B | -1.54% | 81,104 | - |
| 321 | TNDM | Tandem Diabetes Care, Inc. | 1.32B | -2.77% | 532,710 | 1.01B |
| 322 | PLSE | Pulse Biosciences, Inc. | 1.32B | -3.59% | 145,367 | 751.00K |
| 323 | NVAX | Novavax, Inc. | 1.31B | -0.93% | 1,963,104 | 1.12B |
| 324 | QURE | uniQure N.V. | 1.31B | 0.29% | 937,970 | 18.09M |
| 325 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | -3.06% | 413,643 | - |
| 326 | SVRA | Savara Inc. | 1.30B | -3.21% | 464,023 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.29B | -3.62% | 208,498 | - |
| 328 | BFLY | Butterfly Network, Inc. | 1.28B | 1.34% | 3,110,023 | 102.92M |
| 329 | OLMA | Olema Pharmaceuticals, Inc. | 1.26B | -1.06% | 413,634 | - |
| 330 | MPLT | MapLight Therapeutics, Inc. | 1.26B | -2.80% | 105,041 | - |
| 331 | JBIO | Jade Biosciences, Inc. | 1.23B | 1.79% | 137,028 | - |
| 332 | CMPS | COMPASS Pathways plc | 1.23B | -4.10% | 1,702,145 | - |
| 333 | TDOC | Teladoc Health, Inc. | 1.22B | 2.26% | 3,710,682 | 2.51B |
| 334 | MLTX | MoonLake Immunotherapeutics | 1.22B | -3.02% | 295,958 | - |
| 335 | ZBIO | Zenas BioPharma, Inc. | 1.21B | -5.29% | 169,089 | 10.00M |
| 336 | DBVT | DBV Technologies S.A. | 1.16B | 0.67% | 112,149 | 5.74M |
| 337 | PHAR | Pharming Group N.V. | 1.16B | -0.37% | 1,198 | 376.13M |
| 338 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | -3.50% | 65,879 | 83.72M |
| 339 | NEO | NeoGenomics, Inc. | 1.16B | -1.28% | 675,859 | 745.97M |
| 340 | AVNS | Avanos Medical, Inc. | 1.15B | 0.22% | 459,578 | 715.90M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.15B | -5.57% | 255,607 | - |
| 342 | AZTA | Azenta, Inc. | 1.15B | 2.22% | 1,274,366 | 595.03M |
| 343 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | 1.39% | 111,605 | 780.57M |
| 344 | URGN | UroGen Pharma Ltd. | 1.14B | 0.11% | 290,755 | 109.79M |
| 345 | EYPT | EyePoint, Inc. | 1.12B | -3.29% | 444,780 | 31.37M |
| 346 | EVO | Evotec SE | 1.11B | 0.48% | 14,517 | 925.65M |
| 347 | IRMD | IRADIMED CORPORATION | 1.11B | 1.85% | 69,815 | 86.28M |
| 348 | CNMD | CONMED Corporation | 1.10B | 1.95% | 262,144 | 1.37B |
| 349 | ALVO | Alvotech | 1.10B | -0.28% | 85,028 | 588.90M |
| 350 | PNTG | The Pennant Group, Inc. | 1.09B | 0.51% | 64,123 | 947.71M |
| 351 | COAG | Hemab Therapeutics Holdings, Inc. | 1.09B | -2.82% | 316,325 | - |
| 352 | INNV | InnovAge Holding Corp. | 1.08B | -2.69% | 172,811 | 915.37M |
| 353 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -1.58% | 780,390 | 291.85M |
| 354 | USPH | U.S. Physical Therapy, Inc. | 1.07B | 0.04% | 99,734 | 773.34M |
| 355 | CDNA | CareDx, Inc. | 1.07B | -0.95% | 209,124 | 412.82M |
| 356 | SEPN | Septerna, Inc. | 1.06B | -5.00% | 170,634 | 45.95M |
| 357 | OMER | Omeros Corporation | 1.06B | -1.68% | 449,386 | - |
| 358 | IVA | Inventiva S.A. | 1.05B | 3.04% | 227,167 | 7.94M |
| 359 | AKTS | Aktis Oncology, Inc. | 1.05B | -0.05% | 57,596 | 6.50M |
| 360 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.04B | 2.68% | 160,835 | 719.89M |
| 361 | BLFS | BioLife Solutions, Inc. | 1.04B | 1.71% | 130,770 | 96.21M |
| 362 | IART | Integra LifeSciences Holdings Corporation | 1.03B | 24.32% | 1,779,061 | 1.64B |
| 363 | GERN | Geron Corporation | 1.03B | 2.23% | 9,812,259 | 183.88M |
| 364 | CRON | Cronos Group Inc. | 1.00B | -0.57% | 793,521 | 146.59M |
| 365 | WGS | GeneDx Holdings Corp. | 1.00B | -50.24% | 8,448,175 | 442.68M |
| 366 | MRVI | Maravai LifeSciences Holdings, Inc. | 991.41M | 1.32% | 598,600 | 185.74M |
| 367 | PCRX | Pacira BioSciences, Inc. | 986.26M | 1.52% | 228,715 | 734.86M |
| 368 | PHAT | Phathom Pharmaceuticals, Inc. | 977.78M | -4.35% | 597,509 | 204.89M |
| 369 | ORIC | ORIC Pharmaceuticals, Inc. | 960.64M | -3.63% | 829,054 | - |
| 370 | SANA | Sana Biotechnology, Inc. | 955.98M | 1.03% | 920,263 | - |
| 371 | CERT | Certara, Inc. | 949.08M | - | 737,279 | 418.84M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 947.64M | -3.24% | 252,076 | 1.02B |
| 373 | XNCR | Xencor, Inc. | 945.87M | -4.49% | 306,305 | 125.58M |
| 374 | LBRX | LB Pharmaceuticals Inc | 942.14M | 3.22% | 70,952 | - |
| 375 | OMDA | Omada Health, Inc. | 941.73M | 0.83% | 408,541 | 260.21M |
| 376 | SDGR | Schrödinger, Inc. | 932.41M | -2.09% | 848,378 | 255.87M |
| 377 | ANNX | Annexon, Inc. | 916.54M | -0.88% | 721,381 | - |
| 378 | MGTX | MeiraGTx Holdings plc | 913.54M | 1.75% | 269,123 | 81.39M |
| 379 | INMD | InMode Ltd. | 908.56M | 0.21% | 310,084 | 370.50M |
| 380 | SLS | SELLAS Life Sciences Group, Inc. | 906.98M | -2.09% | 1,949,580 | - |
| 381 | ANRO | Alto Neuroscience, Inc. | 891.74M | 0.99% | 167,647 | - |
| 382 | CTMX | CytomX Therapeutics, Inc. | 888.19M | -2.39% | 1,395,917 | 76.20M |
| 383 | BVS | Bioventus Inc. | 882.64M | 4.03% | 263,562 | 568.09M |
| 384 | SPRY | ARS Pharmaceuticals, Inc. | 881.76M | 0.57% | 745,088 | 84.28M |
| 385 | MNKD | MannKind Corporation | 881.61M | 1.60% | 1,681,334 | 348.97M |
| 386 | CGEM | Cullinan Therapeutics, Inc. | 877.02M | -5.54% | 563,134 | - |
| 387 | JANX | Janux Therapeutics, Inc. | 869.89M | -0.83% | 449,214 | 10.00M |
| 388 | TALK | Talkspace, Inc. | 867.36M | -0.17% | 2,637,788 | 228.87M |
| 389 | EVMN | Evommune, Inc. | 864.08M | 1.52% | 592,511 | 13.00M |
| 390 | ABUS | Arbutus Biopharma Corporation | 863.58M | -0.11% | 212,597 | 14.08M |
| 391 | NUTX | Nutex Health Inc. | 860.86M | -15.00% | 146,341 | 879.95M |
| 392 | TBPH | Theravance Biopharma, Inc. | 860.45M | -1.18% | 131,990 | 107.46M |
| 393 | GDRX | GoodRx Holdings, Inc. | 859.86M | 0.40% | 1,116,579 | 796.85M |
| 394 | OPK | OPKO Health, Inc. | 849.48M | 1.35% | 979,617 | 581.12M |
| 395 | DSGN | Design Therapeutics, Inc. | 848.17M | 3.11% | 285,015 | - |
| 396 | ABSI | Absci Corporation | 846.41M | -3.11% | 4,375,190 | 2.80M |
| 397 | SPTX | Seaport Therapeutics, Inc. | 842.88M | -6.50% | 556,410 | - |
| 398 | ETON | Eton Pharmaceuticals, Inc. | 838.85M | 1.66% | 372,883 | 79.95M |
| 399 | VOR | Vor Biopharma Inc. | 837.44M | 5.06% | 486,592 | - |
| 400 | QDEL | QuidelOrtho Corporation | 834.17M | -1.37% | 744,205 | 2.73B |
| 401 | AMN | AMN Healthcare Services, Inc. | 815.65M | 1.83% | 430,441 | 2.73B |
| 402 | KURA | Kura Oncology, Inc. | 811.29M | -1.19% | 382,005 | 67.48M |
| 403 | SGP | SpyGlass Pharma, Inc. | 809.26M | -0.82% | 55,030 | - |
| 404 | DRUG | Bright Minds Biosciences Inc. | 809.25M | 0.67% | 140,992 | - |
| 405 | ESPR | Esperion Therapeutics, Inc. | 803.10M | - | 16,894,862 | 403.14M |
| 406 | SSII | SS Innovations International, Inc. | 797.76M | -1.48% | 27,522 | 42.48M |
| 407 | CBLL | CeriBell, Inc. | 767.68M | - | 182,781 | 89.06M |
| 408 | RLMD | Relmada Therapeutics, Inc. | 764.64M | -1.62% | 316,630 | - |
| 409 | CSTL | Castle Biosciences, Inc. | 754.98M | -2.35% | 123,349 | 344.23M |
| 410 | GYRE | Gyre Therapeutics, Inc. | 752.67M | -2.02% | 33,154 | 116.59M |
| 411 | IRWD | Ironwood Pharmaceuticals, Inc. | 746.81M | -0.22% | 2,689,929 | 296.15M |
| 412 | TENX | Tenax Therapeutics, Inc. | 746.58M | -4.80% | 235,360 | - |
| 413 | ALLO | Allogene Therapeutics, Inc. | 744.71M | -4.20% | 3,481,575 | 22.00K |
| 414 | TRAX | First Tracks Biotherapeutics, Inc. | 731.29M | 2.41% | 202,454 | - |
| 415 | BIOA | BioAge Labs, Inc. | 721.91M | -2.17% | 117,913 | 9.00M |
| 416 | EHAB | Enhabit, Inc. | 697.19M | 0.04% | 145,199 | 1.06B |
| 417 | HSTM | HealthStream, Inc. | 686.92M | 10.31% | 181,502 | 311.78M |
| 418 | TLRY | Tilray Brands, Inc. | 684.68M | -2.71% | 4,564,325 | 858.28M |
| 419 | LXRX | Lexicon Pharmaceuticals, Inc. | 684.24M | 0.94% | 1,219,247 | 49.80M |
| 420 | BWAY | BrainsWay Ltd. | 671.34M | -0.21% | 56,946 | 52.23M |
| 421 | SLDB | Solid Biosciences Inc. | 670.19M | -5.81% | 636,982 | - |
| 422 | ARVN | Arvinas, Inc. | 663.28M | -3.80% | 414,376 | 262.60M |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 662.67M | -2.13% | 90,807 | - |
| 424 | FBRX | Forte Biosciences, Inc. | 662.63M | -5.05% | 73,862 | - |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 656.42M | 3.75% | 633,672 | 7.83M |
| 426 | DRTS | Alpha Tau Medical Ltd. | 643.35M | -2.92% | 606,084 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 625.44M | 5.27% | 601,121 | 106.47M |
| 428 | STRO | Sutro Biopharma, Inc. | 620.47M | -2.45% | 133,335 | 102.48M |
| 429 | CTKB | Cytek Biosciences, Inc. | 619.61M | 3.43% | 430,937 | 201.49M |
| 430 | CRMD | CorMedix Inc. | 607.03M | -2.03% | 477,166 | 311.71M |
| 431 | PRME | Prime Medicine, Inc. | 603.17M | -1.87% | 1,443,310 | 4.63M |
| 432 | PSNL | Personalis, Inc. | 601.90M | -2.54% | 1,245,977 | 69.65M |
| 433 | SIBN | SI-BONE, Inc. | 598.18M | 1.27% | 309,346 | 200.93M |
| 434 | AGMB | AgomAb Therapeutics NV | 593.44M | -0.45% | 41,229 | - |
| 435 | ANL | Adlai Nortye Ltd. | 592.00M | -1.14% | 173,566 | 5.00M |
| 436 | ALT | Altimmune, Inc. | 591.34M | 0.83% | 2,401,710 | 41.00K |
| 437 | PRTA | Prothena Corporation plc | 591.09M | 1.76% | 160,152 | 9.68M |
| 438 | PHR | Phreesia, Inc. | 586.97M | -0.10% | 420,029 | 480.59M |
| 439 | AVR | Anteris Technologies Global Corp. | 581.55M | 1.31% | 211,604 | 1.91M |
| 440 | AURA | Aura Biosciences, Inc. | 577.80M | 7.78% | 2,419,659 | - |
| 441 | TRDA | Entrada Therapeutics, Inc. | 577.09M | 0.03% | 239,305 | 25.42M |
| 442 | NPCE | NeuroPace, Inc. | 574.44M | 0.12% | 41,707 | 99.99M |
| 443 | PROK | ProKidney Corp. | 570.71M | 0.53% | 320,774 | 893.00K |
| 444 | CBIO | Crescent Biopharma, Inc. | 568.05M | -4.60% | 207,639 | 11.88M |
| 445 | DNA | Ginkgo Bioworks Holdings, Inc. | 561.12M | -2.72% | 947,662 | 170.16M |
| 446 | CADL | Candel Therapeutics, Inc. | 555.58M | 0.73% | 1,989,466 | - |
| 447 | KYTX | Kyverna Therapeutics, Inc. | 552.04M | 1.33% | 454,306 | - |
| 448 | TECX | Tectonic Therapeutic, Inc. | 546.98M | -2.12% | 58,877 | - |
| 449 | EIKN | Eikon Therapeutics, Inc. | 546.80M | -1.66% | 82,004 | - |
| 450 | MDXG | MiMedx Group, Inc. | 545.14M | 1.39% | 733,303 | 389.42M |
| 451 | TCMD | Tactile Systems Technology, Inc. | 544.40M | 7.60% | 500,191 | 343.52M |
| 452 | RIGL | Rigel Pharmaceuticals, Inc. | 542.39M | -0.64% | 86,296 | 294.28M |
| 453 | CERS | Cerus Corporation | 537.99M | -1.29% | 1,501,592 | 216.56M |
| 454 | CTNM | Contineum Therapeutics, Inc. | 532.79M | 0.85% | 72,146 | - |
| 455 | ENGN | enGene Therapeutics Inc. | 527.21M | 3.42% | 283,857 | - |
| 456 | CLYM | Climb Bio, Inc. | 521.15M | 12.59% | 1,011,629 | - |
| 457 | AQST | Aquestive Therapeutics, Inc. | 517.02M | -1.42% | 549,166 | 44.55M |
| 458 | VSTM | Verastem, Inc. | 514.76M | -1.51% | 521,291 | 30.91M |
| 459 | VALN | Valneva SE | 509.41M | 1.74% | 4,707 | 205.07M |
| 460 | OCGN | Ocugen, Inc. | 506.08M | -19.19% | 24,079,714 | 4.41M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 462 | PRLD | Prelude Therapeutics Incorporated | 496.73M | 4.22% | 176,757 | 12.14M |
| 463 | OVID | Ovid Therapeutics Inc. | 496.62M | -2.05% | 1,362,174 | 7.25M |
| 464 | OFIX | Orthofix Medical Inc. | 493.78M | 2.41% | 486,749 | 825.37M |
| 465 | XOMA | XOMA Royalty Corporation | 493.31M | 0.88% | 107,350 | 52.15M |
| 466 | STTK | Shattuck Labs, Inc. | 491.66M | -6.00% | 321,755 | 1.00M |
| 467 | WEAV | Weave Communications, Inc. | 489.80M | 1.31% | 836,787 | 248.72M |
| 468 | FDMT | 4D Molecular Therapeutics, Inc. | 489.58M | 1.59% | 298,671 | 85.21M |
| 469 | UPB | Upstream Bio, Inc. | 483.79M | -4.51% | 139,340 | 2.85M |
| 470 | IMMX | Immix Biopharma, Inc. | 482.94M | -3.90% | 515,608 | - |
| 471 | VREX | Varex Imaging Corporation | 480.82M | -1.21% | 85,985 | 854.40M |
| 472 | ZURA | Zura Bio Limited | 478.67M | -5.17% | 333,904 | - |
| 473 | LYEL | Lyell Immunopharma, Inc. | 475.52M | -1.64% | 27,879 | 36.00K |
| 474 | PACB | Pacific Biosciences of California, Inc. | 475.05M | -1.29% | 3,303,122 | 160.01M |
| 475 | KMDA | Kamada Ltd. | 472.88M | -0.84% | 18,611 | 180.46M |
| 476 | SGMT | Sagimet Biosciences Inc. | 472.40M | -3.16% | 861,221 | - |
| 477 | EBS | Emergent BioSolutions Inc. | 472.11M | 7.14% | 897,578 | 676.80M |
| 478 | RGNX | REGENXBIO Inc. | 467.65M | -3.51% | 199,662 | 170.44M |
| 479 | ASMB | Assembly Biosciences, Inc. | 467.24M | 5.68% | 331,128 | 72.30M |
| 480 | MYGN | Myriad Genetics, Inc. | 463.24M | -0.71% | 621,502 | 824.50M |
| 481 | ADCT | ADC Therapeutics SA | 461.70M | -1.36% | 1,432,069 | 79.18M |
| 482 | FULC | Fulcrum Therapeutics, Inc. | 459.10M | -1.85% | 322,683 | 80.00M |
| 483 | ANGO | AngioDynamics, Inc. | 456.42M | -0.27% | 89,605 | 313.73M |
| 484 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.69M | -4.25% | 137,238 | - |
| 485 | CABA | Cabaletta Bio, Inc. | 454.20M | 6.53% | 7,214,821 | - |
| 486 | NGNE | Neurogene Inc. | 451.61M | 2.48% | 62,858 | 925.00K |
| 487 | VNDA | Vanda Pharmaceuticals Inc. | 446.20M | -1.85% | 469,990 | 216.11M |
| 488 | BBNX | Beta Bionics, Inc. | 444.73M | -2.35% | 152,285 | 110.24M |
| 489 | AVIR | Atea Pharmaceuticals, Inc. | 443.77M | -2.28% | 107,477 | - |
| 490 | EVH | Evolent Health, Inc. | 436.12M | -4.14% | 1,270,052 | 1.88B |
| 491 | AUTL | Autolus Therapeutics plc | 433.81M | 3.82% | 1,134,658 | 75.39M |
| 492 | LXEO | Lexeo Therapeutics, Inc. | 429.70M | - | 189,223 | - |
| 493 | AGL | agilon health, inc. | 428.82M | -4.45% | 120,379 | 5.93B |
| 494 | CGC | Canopy Growth Corporation | 425.47M | - | 5,648,255 | 203.04M |
| 495 | NRC | NRC Health | 425.04M | 3.51% | 66,978 | 138.64M |
| 496 | CATX | Perspective Therapeutics, Inc. | 424.72M | -6.41% | 2,010,059 | 884.00K |
| 497 | AVTX | Avalo Therapeutics, Inc. | 423.69M | 15.09% | 400,725 | 59.00K |
| 498 | LRMR | Larimar Therapeutics, Inc. | 421.76M | -3.79% | 649,799 | - |
| 499 | KIDS | OrthoPediatrics Corp. | 421.23M | 3.93% | 133,985 | 243.30M |
| 500 | SRTA | Strata Critical Medical, Inc. | 421.00M | -0.61% | 606,030 | 197.14M |